Cytomegalovirus Cell Mediated Immunity
2 clinical trials · Condition
◉ Watch Cytomegalovirus Cell Mediated Immunity
| Record | Firm | Date |
|---|---|---|
| Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND) (NCT06814301) | Maimónides Biomedical Research Institute of Córdoba | 2025-12-01 |
| The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients (NCT06639854) | M.D. Anderson Cancer Center | 2024-11-20 |
Track Cytomegalovirus Cell Mediated Immunity automatically
Every clearance here is in the API, with alerts when new ones post.